CHTR DEADLINE REMINDER: Important October 14, 2025 Deadline Reminder Charter Communications, Inc. (CHTR) Securities Class Action Lawsuit — Neutral
CHTR PRNewsWire — October 10, 2025RADNOR, Pa. , Oct. 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Charter Communications, Inc. ("Charter") (NASDAQ: CHTR) on behalf of those who purchased or otherwise acquired Charter securities, including purchasers of call options, or sellers of put options, between July 26, 2024, and July 24, 2025, inclusive (the "Class Period").
New Strong Sell Stocks for October 10th — Negative
BMRRY SAR Zacks Investment Research — October 10, 2025CMAKY, BMRRY and SAR have been added to the Zacks Rank #5 (Strong Sell) List on October 10, 2025.
Is the Options Market Predicting a Spike in BCP Investment Stock? — Neutral
BCIC Zacks Investment Research — October 10, 2025Investors need to pay close attention to BCIC stock based on the movements in the options market lately.
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman — Neutral
NUTX PRNewsWire — October 10, 2025SAN FRANCISCO , Oct. 10, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and triggering substantial losses.
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock — Neutral
XBIO Accesswire — October 10, 2025FRAMINGHAM, MA / ACCESS Newswire / October 10, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today announced the pricing of an underwritten offering of 735,000 shares of common stock at a price to the public of $6.12 per share, for gross proceeds of approximately $4.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses. All shares of common stock are being offered by Xenetic.
How Modine's 80/20 Strategy Is Steering Its Transformation? — Positive
MOD Zacks Investment Research — October 10, 2025MOD's 80/20 strategy is reshaping operations, driving efficiency and fueling growth in key thermal management markets.
Serve Robotics: The Robotics Revolution Just Accelerated — Positive
SERV Seeking Alpha — October 10, 2025Serve Robotics surged over 54% since my June article, driven by a new DoorDash partnership expanding its market beyond Uber. The DASH partnership expands SERV's geographic reach and order volume, signaling growing demand for autonomous last-mile delivery beyond Uber. SERV is on track to exceed its 2,000-robot deployment goal, supporting management's revenue run-rate guidance and potential upward sales estimate revisions.
UK slaps Google Search with special market status, making way for stricter regulations — Negative
GOOG GOOGL TechCrunch — October 10, 2025The United Kingdom's Competition and Markets Authority (CMA) on Friday designated Google with a special status in the market for online search that would enable the regulator to enforce stricter regulations.
Bitfarms Converts Macquarie Debt Facility to $300M Project Financing and Draws Additional $50M to Accelerate HPC/AI Development at Panther Creek Campus — Neutral
BITF GlobeNewsWire — October 10, 2025-$300 million facility to fund Phase 1 of Panther Creek data center development with energization expected by YE 2026--On track to break ground on Panther Creek data center in Q4 2025-
Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit -- Hagens Berman — Neutral
AI PRNewsWire — October 10, 2025SAN FRANCISCO , Oct. 10, 2025 /PRNewswire/ -- A new class action lawsuit is targeting enterprise AI software company C3.ai (NYSE: AI) and its senior leadership, alleging they misled investors about the company's financial health and growth prospects. The suit, filed in the U.S. District Court for the Northern District of California, claims that C3.ai and certain executives violated the Securities Exchange Act of 1934.
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million — Neutral
QNRX GlobeNewsWire — October 10, 2025PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital Management, ADAR1 Capital Management, and Velan Capital, among others PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital Management, ADAR1 Capital Management, and Velan Capital, among others
Hancock Whitney Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Positive
HWC Benzinga — October 10, 2025Hancock Whitney Corporation (NYSE:HWC) will release earnings results for the third quarter, after the closing bell on Tuesday, Oct. 14.
Gold prices hit all-time highs this week. Rick Ducat looks at correlation studies between gold prices, the S&P 500 (SPX) and the Cboe Volatility Index (VIX) to demonstrate historical patterns.
JM Smucker Is A Cash Generating Machine: Should You Consider SJM Stock? — Positive
SJM Forbes — October 10, 2025Here's why we believe JM Smucker (SJM) deserves your attention.
Ferrari (RACE) stock dropped nearly 15% yesterday on disappointing projections from management, but here is something interesting. It now deserves a spot on your radar.
Zacks Small-Cap Research Initiates Coverage on NewGen — Neutral
NIVF GlobeNewsWire — October 10, 2025BANGKOK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that Zacks Small-Cap Research ("Zacks") has initiated equity research coverage on the Company. The full equity research report is available on the Zacks website here.
Big Gains Alert: These 3 Tech Stocks Are Surging This Month — Positive
ARQQ ASTS DPRO MarketBeat — October 10, 2025Many investors allocate a portion of their portfolio to stock picking and trading strategies. One popular tactic is tracking stocks with the highest percentage gains, as these moves often signal strong momentum and bullish sentiment.
Applied Digital stock soars on Q1 revenue beat, data center capacity expansion — Positive
APLD Proactive Investors — October 10, 2025Applied Digital Corp (NASDAQ: APLD) shares surged 28% in pre-market trading on Friday after the digital infrastructure provider reported better-than-expected financial results for its fiscal first quarter 2026 and revealed plans for a significant expansion of its data center capacity. Applied Digital's revenue for the quarter rose 84% year over year to $64.2 million, surpassing the analyst consensus estimate of $54.6 million.
Can Stride Sustain Double-Digit EPS Growth as Investments Rise? — Neutral
LRN Zacks Investment Research — October 10, 2025LRN's push into AI-driven learning, tutoring and career initiatives can determine if its double-digit EPS growth endures.